CoRegen, Inc.
Biotechnology company · Houston, Texas, United States
CoRegen, Inc. is a biotechnology company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $14 million sold in a notice filed in 2026.
CoRegen at a glance
What does CoRegen do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $13.5 million sold (2026).
Frequently asked questions about CoRegen
Where is CoRegen headquartered?
CoRegen, Inc. is headquartered in Houston, Texas, United States.
What does CoRegen do?
CoRegen, Inc. is a biotechnology company.
When was CoRegen founded?
The earliest incorporation on record for CoRegen, Inc. is in 2022, according to public company registers.
Similar companies
- Pulmotect, Inc.Houston, Texas, United States
- Kiromic Biopharma, Inc.Houston, Texas, United States
- March Biosciences, Inc.Houston, Texas, United States
- Autoimmunity Biologic Solutions Inc.Houston, Texas, United States
- Fannin Partners, LLCHouston, Texas, United States
- Brevitest Technologies, Inc.Houston, Texas, United States
- Pupil Bio, Inc.Houston, Texas, United States
- Asylia Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences